BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 22083183)

  • 1. [Chemotherapy-induced peripheral neuropathy].
    Noguchi E; Maeda Y
    Gan To Kagaku Ryoho; 2011 Nov; 38(11):1773-6. PubMed ID: 22083183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical identification of predictors for peripheral neuropathy associated with administration of bortezomib, taxanes, oxaliplatin or vincristine using ordered logistic regression analysis.
    Kanbayashi Y; Hosokawa T; Okamoto K; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Taniwaki M
    Anticancer Drugs; 2010 Oct; 21(9):877-81. PubMed ID: 20679888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice.
    Wickham R
    Clin J Oncol Nurs; 2007 Jun; 11(3):361-76. PubMed ID: 17623621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updating your peripheral neuropathy "know-how".
    Marrs J; Newton S
    Clin J Oncol Nurs; 2003; 7(3):299-303. PubMed ID: 12793336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
    Amara S
    Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents.
    Argyriou AA; Zolota V; Kyriakopoulou O; Kalofonos HP
    J BUON; 2010; 15(3):435-46. PubMed ID: 20941808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy-induced neuropathy: A comprehensive survey.
    Miltenburg NC; Boogerd W
    Cancer Treat Rev; 2014 Aug; 40(7):872-82. PubMed ID: 24830939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy-induced peripheral neuropathy: an unresolved issue].
    Velasco R; Bruna J
    Neurologia; 2010 Mar; 25(2):116-31. PubMed ID: 20487712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy.
    Hausheer FH; Schilsky RL; Bain S; Berghorn EJ; Lieberman F
    Semin Oncol; 2006 Feb; 33(1):15-49. PubMed ID: 16473643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.
    Wolf S; Barton D; Kottschade L; Grothey A; Loprinzi C
    Eur J Cancer; 2008 Jul; 44(11):1507-15. PubMed ID: 18571399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives.
    Ewertz M; Qvortrup C; Eckhoff L
    Acta Oncol; 2015 May; 54(5):587-91. PubMed ID: 25751757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and psychometric evaluation of the chemotherapy-induced peripheral neuropathy assessment tool.
    Tofthagen CS; McMillan SC; Kip KE
    Cancer Nurs; 2011; 34(4):E10-20. PubMed ID: 21242773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk-reduction and treatment of chemotherapy-induced peripheral neuropathy.
    Bakogeorgos M; Georgoulias V
    Expert Rev Anticancer Ther; 2017 Nov; 17(11):1045-1060. PubMed ID: 28868935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings.
    Ibrahim EY; Ehrlich BE
    Crit Rev Oncol Hematol; 2020 Jan; 145():102831. PubMed ID: 31783290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient perceptions associated with chemotherapy-induced peripheral neuropathy.
    Tofthagen C
    Clin J Oncol Nurs; 2010 Jun; 14(3):E22-8. PubMed ID: 20529785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review.
    Schloss JM; Colosimo M; Airey C; Masci PP; Linnane AW; Vitetta L
    Clin Nutr; 2013 Dec; 32(6):888-93. PubMed ID: 23647723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral neuropathy induced by microtubule-stabilizing agents.
    Lee JJ; Swain SM
    J Clin Oncol; 2006 Apr; 24(10):1633-42. PubMed ID: 16575015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy-induced peripheral neuropathy: prevention and treatment.
    Pachman DR; Barton DL; Watson JC; Loprinzi CL
    Clin Pharmacol Ther; 2011 Sep; 90(3):377-87. PubMed ID: 21814197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of peripheral neuropathy caused by microtubule inhibitors.
    Donovan D
    Clin J Oncol Nurs; 2009 Dec; 13(6):686-94. PubMed ID: 19948466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy-induced peripheral neuropathy: Symptomatology and epidemiology].
    Kerckhove N; Collin A; Condé S; Chaleteix C; Pezet D; Balayssac D; Guastella V
    Bull Cancer; 2018 Nov; 105(11):1020-1032. PubMed ID: 30244980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.